Litigation Details for Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al. (D. Mass. 2015)
✉ Email this page to a colleague
Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al. (D. Mass. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-05-05 |
Court | District Court, D. Massachusetts | Date Terminated | 2016-04-05 |
Cause | Assigned To | Patti B. Saris | |
Jury Demand | Referred To | ||
Patents | 7,491,403 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al.
The biologic drugs covered by the patent cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al. (D. Mass. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-05-05 | 1 | Complaint | 7,270,826; 7,335,367; 7,459,164; 7,491,403; 7,537,773; 7,670,608; 7,691,394; 7,943,152; 8,580,745; 8,691,769…knowledge and owns composition and application patents for PurTox that are complementary to the purified…purified neurotoxin technology, including U.S. Patent Nos. 5,401,243; 5,298,019; 5,696,077; 6,429,189; 7,270,826…notice to WARF. 29. BTRA identified a patent infringement issue by Allergan, Inc. during this… Johnson objected stating that the transfer of patent enforcement claims would "be contrary to the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |